Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

cysteine/atrofi

Tautan disimpan ke clipboard
Halaman 1 dari 22 hasil

Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD The present invention relates to the field of anti-aging of skin. Specifically, the invention relates to novel compositions and methods of using the compositions for effacing and preventing wrinkles in mammalian skin. BACKGROUND OF THE INVENTION Skin is subject to abuse by many
CROSS REFERENCE TO RELATED APPLICATIONS AND CLAIM OF PRIORITY This patent application is a National Stage entry from International Application No. PCT/KR2013/007420, filed Aug. 19, 2013, which claims priority to Korean Patent Application No. 10-2012-0089857, filed Aug. 17, 2012, entire contents of

Formulations for reducing neuronal degeneration

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD This invention relates to treatment of neurodegenerative disorders, and more particularly to Alzheimer's disease and Parkinson's disease. BACKGROUND Oxidative stress plays a role in neurodegeneration, regardless of etiology. Physical trauma or secondary effects of insult to the

Composition and method for combating macular degeneration

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention generally relates to a method and composition for the alleviation of eye diseases and, more specifically, to an improved method and composition for combating macular degeneration. 2. Description of the Related Art Macular

Composition and method for treatment of macular degeneration

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention generally relates to methods and compositions to alleviate eye diseases and, more specifically, to improved methods and compositions for the treatment of cataracts and macular degeneration. 2. Description of the Related
BACKGROUND Cancer is a major public health problem in the United States and other parts of the world. Currently, 1 in 4 deaths in the United States is due to cancer. Angiogenesis plays a critical role in tumor growth and metastasis in most types of cancer. In particular, its importance has been
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ELECTRONICALLY This application contains a sequence listing. It has been submitted electronically via EFS-Web as an ASCII text file entitled "111232-00408_ST25.txt". The sequence listing is 16,384 bytes in size, and was created on Jul. 20, 2015. It is

SMDF and GGF neuregulin splice variant isoforms and uses thereof

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the fields of neurobiology and developmental biology. More specifically, the present invention relates to the identification of novel neuregulin splice variant isoforms. 2. Description of the Related

Process for producing wheat flour and wheat flour products

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION This invention relates to a wheat flour which is used in preparing fresh (undried) noodles, dried noodles and tenobe somen (hand-made thin wheat noodles) and a process for producing the same. More particularly, the present invention relates to a process for suppressing or

Inhibitors of dipeptidyl peptidase I

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION The present invention relates to compounds that act as specific inhibitors of the cysteine protease dipeptidyl peptidase I (DP I). Compounds based on acylated hydroxamates are distinguished by being chemically stable in aqueous solutions, including biological fluids (Bromme

Treatment of chronic hypertension and related conditions with thiol complexes

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION This invention is in the fields of pharmacology and biochemistry. It relates to the synthesis of certain complexes of L-cysteine, N-acetyl L-cysteine, N-(2-mercapto-propionyl)glycine, L-2-oxothiazolidine-4-carboxylate and the nutritional or clinical use of these and other

Various thiol complexes, processes for their synthesis and clinical applications

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION This invention is in the fields of pharmacology and biochemistry. It relates to the synthesis of certain complexes of L-cysteine, N-acetyl L-cysteine, N-(2-mercapto-propionyl)glycine, L-2-oxothiazolidine-4-carboxylate and the nutritional or clinical use of these and other

Compositions and processes for maintaining the fresh sensory attributes of freshly-cut apples

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This invention relates to compositions and processes that maintain the integrity of fruit that generally exhibits loss of color, loss of texture, and changes in flavor or aroma when cut, and is more specifically related to compositions and processes that are effective in preventing the

Ovoglycoprotein and agents for chromatographic separation containing same

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION The present invention relates to a novel ovoglycoprotein and an agent for chromatographic separation and more specifically to an ovoglycoprotein having optical recognizability and an agent serving as a fixed phase for chromatographic separation comprising a carrier and

Angiogenesis inhibitor

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD The present invention relates to an angiogenesis inhibitor comprising a cysteine protease inhibitory compound. BACKGROUND OF THE INVENTION An angiogenesis is a phenomenon wherein new blood vessels are created to form a new vascular network in the living body. The angiogenesis is
Bergabunglah dengan
halaman facebook kami

Database tanaman obat terlengkap yang didukung oleh sains

  • Bekerja dalam 55 bahasa
  • Pengobatan herbal didukung oleh sains
  • Pengenalan herbal melalui gambar
  • Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
  • Baca publikasi ilmiah yang terkait dengan pencarian Anda
  • Cari tanaman obat berdasarkan efeknya
  • Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten

Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan

Google Play badgeApp Store badge